(Reuters) - Johnson & Johnson raised its 2016 sales and earnings forecast and reported quarterly results that beat Wall Street estimates, helped by strength in its prescription drugs business.
Reuters: Business News, Reuters: Business
Tue, 07/19/2016 - 5:21am
(Reuters) - Johnson & Johnson raised its 2016 sales and earnings forecast and reported quarterly results that beat Wall Street estimates, helped by strength in its prescription drugs business.